Back to Search
Start Over
Central nervous system complications after combination treatment with adriamycin (NSC-123127) and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).
- Source :
-
Cancer chemotherapy reports [Cancer Chemother Rep] 1974 Sep-Oct; Vol. 58 (5 Pt 1), pp. 753-4. - Publication Year :
- 1974
- Subjects :
- Adult
Amides adverse effects
Amides therapeutic use
Antineoplastic Agents therapeutic use
Doxorubicin therapeutic use
Drug Evaluation
Drug Therapy, Combination adverse effects
Epilepsies, Partial chemically induced
Epilepsy, Tonic-Clonic chemically induced
Female
Humans
Imidazoles therapeutic use
Male
Melanoma drug therapy
Middle Aged
Sarcoma drug therapy
Triazenes therapeutic use
Antineoplastic Agents adverse effects
Doxorubicin adverse effects
Imidazoles adverse effects
Seizures chemically induced
Triazenes adverse effects
Subjects
Details
- Language :
- English
- ISSN :
- 0069-0112
- Volume :
- 58
- Issue :
- 5 Pt 1
- Database :
- MEDLINE
- Journal :
- Cancer chemotherapy reports
- Publication Type :
- Academic Journal
- Accession number :
- 4214608